Figure 2
Effects of recombinant human Mullerian-inhibiting substance (MIS)/anti-Mullerian hormone (E.Coli derived) on endometriosis epithelial cell line. (A) pre-G1 fraction analysis of endometriosis epithelial cells treated for 24-48-72 hrs with the indicated final concentrations of MIS. The data are shown in a time-dependent manner. (B) pre-G1 fraction analysis of endometriosis epithelial cell line treated for 24-48-72 hrs with the indicated final concentrations of MIS. The data are shown in a dose-dependent manner. (C) Cell cycle analysis of endometriosis epithelial cells treated 24-48-72 hrs with the indicated final concentrations of MIS. The data are shown in a time-dependent manner. (D) Cell cycle analysis of endometriosis epithelial cells treated 24-48-72 hrs with the indicated final concentrations of MIS. The data are shown in a dose-dependent manner.